Inventor · disambiguated record
Petra Blom
Also filed as: BLOM PETRA · BLOM PETRA MARCELLA · BLOM PETRA MARCELLA FRANCOISE · BLOM PETRA MARCELLA FRANÇOISE
10 granted patents·2 pending applications·22 citations·filing 2001–2022
84Inventor score
Files withONCODESIGN SA5IPSEN PHARMA SAS3KEMIN PHARMA B V B A2KEMIN PHARMA EUROP B V B A1SERVIER LAB1
Top patents by PatentIndex Score
12 records- 0182US9090630B2Macrocyclic FLT3 kinase inhibitorsONCODESIGN SA·Filed 2012·Granted Jul 28, 2015·4 cites·14 claims
- 0277US9096609B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2012·Granted Aug 4, 2015·5 cites·10 claims
- 0376US9370520B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2015·Granted Jun 21, 2016·3 cites·9 claims
- 0476US9370519B2Macrocyclic FLT3 kinase inhibitorsONCODESIGN SA·Filed 2015·Granted Jun 21, 2016·3 cites·12 claims
- 0572US10377772B2Macrocyclic LRRK2 kinase inhibitorsONCODESIGN SA·Filed 2015·Granted Aug 13, 2019·2 cites·22 claims
- 0668US7138531B2Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activityKEMIN PHARMA B V B A·Filed 2001·Granted Nov 21, 2006·4 cites·2 claims
- 0762US9586975B2Macrocyclic salt-inducible kinase inhibitorsONCODESIGN SA·Filed 2014·Granted Mar 7, 2017·1 cites·9 claims
- 0851US7534871B2Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activityKEMIN PHARMA B V B A·Filed 2004·Granted May 19, 2009·0 cites·4 claims
- 0951US2024246992A1Macrocyclic lrrk2 kinase inhibitorsSERVIER LAB·Filed 2022·Application pending·0 cites
- 1043US10716869B2Radiolabeled macrocyclic EGFR inhibitorONCODESIGN SA·Filed 2017·Granted Jul 21, 2020·0 cites·9 claims
- 1141US2016031905A1Macrocyclic LRRK2 Kinase InhibitorsIPSEN PHARMA SAS·Filed 2014·Application pending·0 cites
- 1237US7101908B2Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridaeKEMIN PHARMA EUROP B V B A·Filed 2003·Granted Sep 5, 2006·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →